Operating
Change in AR
Regeneron Pharmaceuticals Change in AR decreased by 101.5% to -$1.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 99.8%, from -$657.80M to -$1.20M. Over 3 years (FY 2021 to FY 2024), Change in AR shows a downward trend with a -34.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
A large increase relative to sales growth may signal issues with collections or aggressive credit terms offered to customers.
Detailed definition
This represents the net change in the amount of money owed to the company by customers for goods or services delivered o...
Peer comparison
Companies with strong market power or direct-to-consumer models typically maintain lower accounts receivable relative to total sales.
Metric ID:
change_in_accounts_receivableHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.83B | -$1.54B | $584.50M | -$1.20B | $322.40M | $386.90M | -$219.60M | -$210.10M | $2.70M | $463.50M | $82.70M | -$446.80M | $494.10M | $388.90M | $117.80M | -$657.80M | $28.20M | $80.30M | -$1.20M |
| QoQ Change | — | -154.5% | +137.9% | -304.9% | +126.9% | +20.0% | -156.8% | +4.3% | +101.3% | >999% | -82.2% | -640.3% | +210.6% | -21.3% | -69.7% | -658.4% | +104.3% | +184.8% | -101.5% |
| YoY Change | — | — | — | — | -88.6% | +125.1% | -137.6% | +82.5% | -99.2% | +19.8% | +137.7% | -112.7% | >999% | -16.1% | +42.4% | -47.2% | -94.3% | -79.4% | +99.8% |
Range-$1.54B – $2.83B
CAGR-82.2%
Avg YoY Growth>999%
Median YoY Growth-16.1%
Change in AR at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's change in ar?
- Regeneron Pharmaceuticals (REGN) reported change in ar of -$1.20M in Q1 2026.
- How has Regeneron Pharmaceuticals's change in ar changed year-over-year?
- Regeneron Pharmaceuticals's change in ar increased by 99.8% year-over-year, from -$657.80M to -$1.20M.
- What is the long-term trend for Regeneron Pharmaceuticals's change in ar?
- Over 3 years (2021 to 2024), Regeneron Pharmaceuticals's change in ar has grown at a -34.0% compound annual growth rate (CAGR), from $1.93B to $554.00M.
- What does change in ar mean?
- The change in the amount of money customers owe the company for recent purchases.